This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
An, C.L., Gigliotti, F., and Harmsen, A.G. (2003). Exposure of immunocompetent adult mice to Pneumocystis carinii f. sp. muris by cohousing: Growth of P. carinii f. sp. muris and host immune response. Infect. Immun. 71: 2065–2070.
Angus, C.W., Tu, A., Vogel, P., Qin, M., and Kovacs, J.A. (1996). Expression of variants of the major surface glycoprotein on Pneumocystis carinii. J. Exp. Med. 183: 1229–1234.
Burke, B.A. and Good, R.A. (1973). Pneumocystis carinii infection. Medicine 52: 23–52.
Burns, S.M., Read, J.A., Yap, P.L., and Brettle, R.P. (1990). Reduced concentrations of IgG antibodies to Pneumocystis carinii in HIV-infected patients during active Pneumocystis carinii infection and the possibility of passive immunisation. J. Infect. 20: 33–39.
Chatterton, J.M.W., Joss, A.W.L., Pennington, T.H., and Ho-Yen, D.O. (1999). Usefulness of rat-derived antigen in the serodiagnosis of Pneumocystis carinii infection. J. Med. Microbiol. 48: 681–687.
Garvy, B.A. and Harmsen, A.G. (1996). Susceptibility to Pneumocystis carinii infection: Host responses of neonatal mice from immune or naive mothers and of immune or naive adults. Infect. Immun. 64: 3987–3992.
Garvy, B.A., Wiley, J.A., Gigliotti, F., and Harmsen, A.H. (1997). Protection against Pneumocystis carinii pneumonia by antibodies generated from either T helper 1 or T helper 2 responses. Infect. Immun. 65: 5052–5056.
Gigliotti, F. (1992). Host species-specific antigenic variation of a mannosylated surface glycoprotein of Pneumocystis carinii. J. Infect. Dis. 165: 329–336.
Gigliotti, F. and Hughes, W.T. (1988). Passive immunoprophylaxis with specific monoclonal antibody confers partial protection against Pneumocystis carinii pneumonitis in animal models. J. Clin. Invest. 81: 1666–1668.
Gigliotti, F. and McCool, T. (1996). Glycoprotein A is the immunodominant antigen of Pneumocystis carinii in mice following immunization. Parasitol. Res. 82: 90–91.
Gigliotti, F., Garvy, B.A., and Harmsen, A.G. (1996). Antibody-mediated shift in the profile of glycoprotein A phenotypes observed in a mouse model of Pneumocystis carinii pneumonia. Infect. Immun. 64: 1892–1899.
Gigliotti, F., Garvy, B.A., Haidaris, C.G., and Harmsen, A.G. (1998a). Recognition of Pneumocystis carinii antigens by local antibody-secreting cells following resolution of P. carinii pneumonia in mice. J. Infect. Dis. 178: 235–242.
Gigliotti, F., Wiley, J.A., and Harmsen, A.G. (1998b). Immunization with Pneumocystis carinii gpA is immunogenic but not protective in a mouse model of P. carinii pneumonia. Infect. Immun. 66: 3179–3182.
Gigliotti, F., Haidaris, C.G., Wright, T.W., and Harmsen, A.G. (2002). Passive intranasal monoclonal antibody prophylaxis against murine Pneumocystis carinii pneumonia. Infect. Immun. 70: 1069–1074.
Gigliotti, F., Harmsen, A.G., and Wright, T.W. (2003). Characterization of transmission of Pneumocystis carinii f. sp. muris through immunocompetent BALB/c mice. Infect. Immun. 71: 3852–3856.
Hanano, R., Reifenberg, K., and Kaufmann, S.H.E. (1996). Naturally acquired Pneumocystis carinii pneumonia in gene disruption mutant mice: Roles of distinct T-cell populations in infection. Infect. Immun. 64: 3201–3209.
Harmsen, A.G. and Stankiewicz, M. (1990). Requirement for CD4+ cells in resistance to Pneumocystis carinii pneumonia in mice. J. Exp. Med. 172: 937–945.
Harmsen, A.G. and Stankiewicz, M. (1991). T cells are not sufficient for resistance to Pneumocystis carinii pneumonia in mice. J. Protozool. 38: 44S–45S.
Harmsen, A.G., Chen, W., and Gigliotti, F. (1995). Active immunity to Pneumocystis carinii reinfection in T-cell-depleted mice. Infect. Immun. 63: 2391–2395.
Jain, A., Atkinson, T.P., Lipsky, P.E., Slater, J.E., Nelson, D.L., and Strober, W. (1999). Defects of T-cell effector function and post-thymic maturation in X-linked hyper-IgM syndrome. J. Clin. Invest. 103: 1151–1158.
Jalil, A., Moja, P., Lambert, C., Perol, M., Cotte, L., Livrozet, J.M., Boibieux, A., Vergnon, J.M., Lucht, F., Tran, R., Contini, C., and Genin, C. (2000). Decreased production of local immunoglobulin A to Pneumocystis carinii in bronchoalveolar lavage fluid from human immunodeficiency virus-positive patients. Infect. Immun. 68: 1054–1060.
Laursen, A.L. and Anderson, P.L. (1998). Low levels of IgG antibodies against Pneumocystis carinii among HIV-infected patients. Scand. J. Infect. Dis. 30: 495–499.
Laursen, A.L., Jensen, B.N., and Andersen, P.L. (1994). Local antibodies against Pneumocystis carinii in bronchoalveolar lavage fluid. Eur. Respir. J. 7: 679–685.
Laursen, A.L., Obel, N., Holmskov, U., Jensenius, J.C., Aliouat, E.M., and Anderson, P.L. (2003). Activation of the respiratory burst by Pneumocystis carinii. Efficiency of different antibody isotypes, complement, lung surfactant protein D, and mannan-binding lectin. APMIS 111: 405–415.
Lee, L.H., Gigliotti, F., Wright, T.W., Simpson-Haidaris, P.J., Weinberg, G.A., and Haidaris, C.G. (2000). Molecular characterization of KEX1, a kexin-like protease in mouse Pneumocystis carinii. Gene 242: 141–150.
Lund, F.E., Schuer, K., Hollifield, M., Randall, T.D., and Garvy, B.A. (2003). Clearance of Pneumocystis carinii in mice is dependent on B cells but not on P. carinii-specific antibody. J. Immunol. 171: 1423–1430.
Lundgren, B., Lebech, M., Lind, K., Nielson, J.O., and Lundgren, J.D. (1993). Antibody response to a major human Pneumocystis carinii surface antigen in patients without evidence of immunosuppression and in patients with suspected atypical pneumonia. Eur. J. Microbiol. Infect. Dis. 12: 105–109.
Macy, J.D., Weir, E.C., Compton, S.R., Shlomchik, M.J., and Brownstein, D.G. (2000). Dual infection with Pneumocystis carinii and Pasturella pneumotropica in B cell-deficient mice: Diagnosis and therapy. Lab. Animal Sci. 50: 49–55.
Marcotte, H., Levesque, D., Delanay, K., Bourgeault, A., de la Durantaye, R., Brochu, S., and Lavoie, M.C. (1996). Pneumocystis carinii infection in transgenic B cell-deficient mice. J. Infect. Dis. 173: 1034–1037.
Meuwissen, J.H.E.T., Tauber, I., Leeuwenberg, A.D.E.M., Beckers, J.J.A., and Siebe, M. (1977). Parasitologic and serologic observations of infection with Pneumocystis in humans. J. Infect. Dis. 136: 43–49.
Pascale, J.M., Shaw, M.M., Durant, P.J., Amador, A.A., Bartlett, M.S., Smith, J.W., Gregorty, R.L., and McLaughlin, G.L. (1999). Intranasal immunization confers protection against murine Pneumocystis carinii lung infection. Infect. Immun. 67: 805–809.
Peglow, S.L., Smulian, A.G., Linke, M.J., Pogue, C.L., Nurre, S., Crisler, J., Phair, J., Gold, J.W., Armstrong, D., and Walzer, P.D. (1990). Serologic responses to Pneumocystis carinii antigens in health and disease. J. Infect. Dis. 161: 296–306.
Rao, C.P. and Gelfand, E.W. (1983). Pneumocystis carinii pneumonitis in patients with hypogammaglobulinemia and intact T cell immunity. J. Pediatr. 103: 410–412.
Roths, J.B. and Sidman, C.L. (1992). Both immunity and hyperresponsiveness to Pneumocystis carinii result from transfer of CD4+ but not CD8+ T cells into severe combined immunodeficiency mice. J. Clin. Invest. 90: 673–678.
Roths, J.B. and Sidman, C.L. (1993). Single and combined humoral and cell-mediated immunotherapy of Pneumocystis carinii pneumonia in immunodeficient SCID mice. Infect. Immun. 61: 1641–1649.
Saulsbury, F.T., Bernstein, M.T., and Winkelstein, J.A. (1979). Pneumocystis carinii pneumonia as the presenting infection in congenital hypogammaglobulinemia. J. Pediatr. 95: 559–561.
Smulian, A.G., Sullivan, D.W., Linke, M.J., Halsey, N.A., Quinn, T.C., MacPhail, A.P., Hernandez Avila, M.A., Hong, S.T., and Walzer, P.D. (1993a). Geographic variation in the humoral response to Pneumocystis carinii. J. Infect. Dis. 167: 1243–1247.
Smulian, A.G., Theus, S.A., Denko, N., Walzer, P.D., and Stringer, J.R. (1993b). A 55 kDa antigen of Pneumocystis carinii: Analysis of the cellular immune response and characterization of the gene. Mol. Microbiol. 7: 745–753.
Snydman, D.R., Werner, B.G., Heinze-Lacey, B., Berardi, V.P., Tilney, N.L., Kirkman, R.L., Milford, E.L., Cho, S.I., Bush, H.L., and Levey, A.S. (1987). Use of cytomegalovirus immune globulin to prevent cytomegalovirus disease in renal-transplant recipients. N. Engl. J. Med. 317: 1049–1054.
Soulez, B., Dei-Cas, E., Charet, P., Mougeot, G., Caillaux, M., and Camus, D. (1989). The young rabbit: A nonimmunosuppressed model for Pneumocystis carinii pneumonia. J. Infect. Dis. 160: 355–356.
Stringer, S.L., Garbe, T., Sunkin, S.M., and Stringer, J.R. (1993). Genes encoding antigenic surface glycoproteins in Pneumocystis carinii from humans. J. Eukaryot. Microbiol. 40: 821–826.
Stringer, J.R., Cushion, M.T., and Wakefield, A. (2001). New nomenclature for the genus Pneumocystis. J. Eukaryot. Microbiol. Suppl: 184S–189S.
Tanaka, S., Kaji, Y., Taniyama, H., Matsukawa, K., Ochiai, K., and Itakura, C. (1994). Pneumocystis carinii pneumonia in a thoroughbred foal. J. Vet. Med. Sci. 56: 135–137.
Theus, S.A., Sullivan, D.W., Walzer, P.D., and Smulian, A.G. (1994). Cellular responses to a 55-kilodalton recombinant Pneumocystis carinii antigen. Infect. Immun. 62: 3479–3484.
Vargas, S.L., Ponce, C.A., Hughes, W.T., Wakefield, A.E., Weitz, J.C., Donoso, S., Ulloa, A.V., Madrid, P., Gould, S., Latorre, J.J., Ávila, R., Benveniste, S., Gallor, M., Belletti, J., and López, R. (1999). Association of primary Pneumocystis carinii infection and sudden infant death syndrome. Clin. Infect. Dis. 29: 1489–1493.
Vargas, S.L., Hughes, W.T., Santolaya, M.E., Ulloa, A.V., Ponce, C.A., Cabrera, C.E., Cumsille, F., and Gigliotti, F. (2001). Search for primary infection by Pneumocystis carinii in a cohort of normal, healthy infants. Clin. Infect. Dis. 32: 855–861.
Wada, M., Sunkin, S.M., Stringer, J.R., and Nakamura, Y. (1995). Antigenic variation by positional control of major surface glycoprotein gene expression in Pneumocystis carinii. J. Infect. Dis. 171: 1563–1568.
Walzer, P.D. and Rutledge, M.E. (1981). Humoral immunity in experimental Pneumocystis carinii infection I. Serum and bronchial lavage fluid antibody responses in rats. J. Lab. Clin. Med. 97: 820–833.
Wiley, J.A. and Harmsen, A.G. (1995). CD40 ligand is required for resolution of Pneumocystis carinii pneumonia in mice. J. Immunol. 155: 3525–3529.
Zeitlin, L., Cone, R.A., and Whaley, K.J. (1999). Using monoclonal antibodies to prevent mucosal transmission of epidemic infectious diseases. Emerg. Infect. Dis. 5: 66.
Zheng, M., Shellito, J.E., Marrero, L., Zhong, Q., Julian, S., Ye, P., Wallace, V., Schwarzenberger, P., and Kolls, J.K. (2001). CD4+ T cell-independent vaccination against Pneumocystis carinii in mice. J. Clin. Invest. 108: 1469–1474.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2005 Springer Science+Business Media, Inc.
About this chapter
Cite this chapter
Garvy, B.A., Gigliotti, F. (2005). Antibody-Mediated Immunity to Pneumocystis in the Lungs. In: Fidel, P.L., Huffnagle, G.B. (eds) Fungal Immunology. Springer, Boston, MA. https://doi.org/10.1007/0-387-25445-5_14
Download citation
DOI: https://doi.org/10.1007/0-387-25445-5_14
Publisher Name: Springer, Boston, MA
Print ISBN: 978-0-387-24092-3
Online ISBN: 978-0-387-25445-6
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)